Annual gross profit:
$9.49B+$882.60M(+10.25%)Summary
- As of today (April 25, 2025), VRTX annual gross profit is $9.49 billion, with the most recent change of +$882.60 million (+10.25%) on December 31, 2024.
- During the last 3 years, VRTX annual gross profit has risen by +$2.82 billion (+42.27%).
- VRTX annual gross profit is now at all-time high.
Performance
VRTX Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$2.49B+$109.30M(+4.59%)Summary
- As of today (April 25, 2025), VRTX quarterly gross profit is $2.49 billion, with the most recent change of +$109.30 million (+4.59%) on December 31, 2024.
- Over the past year, VRTX quarterly gross profit has increased by +$338.90 million (+15.76%).
- VRTX quarterly gross profit is now at all-time high.
Performance
VRTX quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$9.49B+$338.90M(+3.70%)Summary
- As of today (April 25, 2025), VRTX TTM gross profit is $9.49 billion, with the most recent change of +$338.90 million (+3.70%) on December 31, 2024.
- Over the past year, VRTX TTM gross profit has increased by +$882.60 million (+10.25%).
- VRTX TTM gross profit is now at all-time high.
Performance
VRTX TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
VRTX Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.3% | +15.8% | +10.3% |
| 3 y3 years | +42.3% | +21.7% | +23.9% |
| 5 y5 years | +162.5% | +21.7% | +23.9% |
VRTX Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.3% | at high | +34.4% | at high | +35.8% |
| 5 y | 5-year | at high | +162.5% | at high | +85.7% | at high | +125.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.49B(+10.3%) | $2.49B(+4.6%) | $9.49B(+3.7%) |
| Sep 2024 | - | $2.38B(+4.6%) | $9.15B(+2.4%) |
| Jun 2024 | - | $2.27B(-3.2%) | $8.94B(+1.0%) |
| Mar 2024 | - | $2.35B(+9.2%) | $8.85B(+2.8%) |
| Dec 2023 | $8.61B(+9.6%) | $2.15B(-0.7%) | $8.61B(+1.5%) |
| Sep 2023 | - | $2.16B(-0.9%) | $8.48B(+1.4%) |
| Jun 2023 | - | $2.18B(+3.6%) | $8.36B(+3.1%) |
| Mar 2023 | - | $2.11B(+4.4%) | $8.11B(+3.3%) |
| Dec 2022 | $7.85B(+17.7%) | $2.02B(-1.2%) | $7.85B(+2.5%) |
| Sep 2022 | - | $2.04B(+5.7%) | $7.66B(+4.0%) |
| Jun 2022 | - | $1.93B(+4.5%) | $7.36B(+5.3%) |
| Mar 2022 | - | $1.85B(+1.5%) | $6.99B(+4.8%) |
| Dec 2021 | $6.67B(+22.0%) | $1.83B(+4.4%) | $6.67B(+6.4%) |
| Sep 2021 | - | $1.75B(+11.6%) | $6.27B(+6.7%) |
| Jun 2021 | - | $1.57B(+2.2%) | $5.87B(+4.0%) |
| Mar 2021 | - | $1.53B(+7.5%) | $5.65B(+3.3%) |
| Dec 2020 | $5.47B(+51.3%) | $1.42B(+5.4%) | $5.47B(+3.7%) |
| Sep 2020 | - | $1.35B(+0.9%) | $5.27B(+11.3%) |
| Jun 2020 | - | $1.34B(-0.9%) | $4.74B(+12.7%) |
| Mar 2020 | - | $1.35B(+10.1%) | $4.20B(+16.3%) |
| Dec 2019 | $3.62B(+37.0%) | $1.23B(+50.2%) | $3.62B(+15.3%) |
| Sep 2019 | - | $817.91M(+1.5%) | $3.13B(+4.8%) |
| Jun 2019 | - | $805.55M(+5.5%) | $2.99B(+5.6%) |
| Mar 2019 | - | $763.34M(+2.1%) | $2.83B(+7.4%) |
| Dec 2018 | $2.64B(+19.2%) | $747.82M(+11.1%) | $2.64B(+7.3%) |
| Sep 2018 | - | $673.28M(+3.9%) | $2.46B(+7.3%) |
| Jun 2018 | - | $647.77M(+13.8%) | $2.29B(+8.3%) |
| Mar 2018 | - | $569.19M(+0.3%) | $2.11B(-4.5%) |
| Dec 2017 | $2.21B(+48.4%) | $567.58M(+12.3%) | $2.21B(+8.3%) |
| Sep 2017 | - | $505.29M(+6.8%) | $2.04B(+7.7%) |
| Jun 2017 | - | $472.93M(-29.2%) | $1.90B(+4.8%) |
| Mar 2017 | - | $667.73M(+67.7%) | $1.81B(+21.5%) |
| Dec 2016 | $1.49B(+64.3%) | $398.22M(+10.7%) | $1.49B(+3.0%) |
| Sep 2016 | - | $359.71M(-6.9%) | $1.45B(+6.0%) |
| Jun 2016 | - | $386.36M(+11.2%) | $1.37B(+21.0%) |
| Mar 2016 | - | $347.43M(-2.0%) | $1.13B(+24.4%) |
| Dec 2015 | $907.82M(+74.8%) | $354.55M(+27.6%) | $907.82M(+32.8%) |
| Sep 2015 | - | $277.86M(+86.2%) | $683.80M(+19.8%) |
| Jun 2015 | - | $149.22M(+18.2%) | $570.75M(+5.2%) |
| Mar 2015 | - | $126.20M(-3.3%) | $542.65M(+4.5%) |
| Dec 2014 | $519.43M(-52.0%) | $130.53M(-20.8%) | $519.43M(-27.6%) |
| Sep 2014 | - | $164.80M(+36.1%) | $717.79M(-4.0%) |
| Jun 2014 | - | $121.12M(+17.6%) | $747.35M(-16.9%) |
| Mar 2014 | - | $102.97M(-68.7%) | $899.05M(-16.9%) |
| Dec 2013 | $1.08B(-13.3%) | $328.89M(+69.2%) | $1.08B(+8.3%) |
| Sep 2013 | - | $194.36M(-28.8%) | $999.08M(-9.4%) |
| Jun 2013 | - | $272.82M(-4.5%) | $1.10B(-2.7%) |
| Mar 2013 | - | $285.63M(+16.0%) | $1.13B(-9.1%) |
| Dec 2012 | $1.25B(-6.2%) | $246.28M(-17.2%) | $1.25B(-18.7%) |
| Sep 2012 | - | $297.47M(-2.1%) | $1.53B(-17.4%) |
| Jun 2012 | - | $303.88M(-23.9%) | $1.86B(+12.0%) |
| Mar 2012 | - | $399.53M(-25.1%) | $1.66B(+24.7%) |
| Dec 2011 | $1.33B(+918.2%) | $533.21M(-14.1%) | $1.33B(+54.8%) |
| Sep 2011 | - | $620.79M(+490.6%) | $859.38M(+231.6%) |
| Jun 2011 | - | $105.12M(+48.1%) | $259.16M(+41.9%) |
| Mar 2011 | - | $71.00M(+13.6%) | $182.57M(+39.8%) |
| Dec 2010 | $130.64M(+49.0%) | $62.48M(+203.8%) | $130.64M(+32.8%) |
| Sep 2010 | - | $20.57M(-27.9%) | $98.41M(-0.7%) |
| Jun 2010 | - | $28.54M(+49.7%) | $99.08M(+14.8%) |
| Mar 2010 | - | $19.06M(-37.0%) | $86.35M(-1.5%) |
| Dec 2009 | $87.69M(-45.1%) | $30.24M(+42.3%) | $87.69M(+1.9%) |
| Sep 2009 | - | $21.25M(+34.5%) | $86.04M(-6.7%) |
| Jun 2009 | - | $15.80M(-22.6%) | $92.21M(-35.1%) |
| Mar 2009 | - | $20.40M(-28.7%) | $142.12M(-11.1%) |
| Dec 2008 | $159.82M | $28.60M(+4.3%) | $159.82M(-10.5%) |
| Sep 2008 | - | $27.41M(-58.3%) | $178.54M(-5.3%) |
| Jun 2008 | - | $65.71M(+72.5%) | $188.58M(+19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $38.10M(-19.5%) | $157.67M(-14.8%) |
| Dec 2007 | $185.11M(-9.3%) | $47.32M(+26.3%) | $185.11M(-19.1%) |
| Sep 2007 | - | $37.45M(+7.6%) | $228.87M(-5.3%) |
| Jun 2007 | - | $34.80M(-46.9%) | $241.59M(+3.4%) |
| Mar 2007 | - | $65.54M(-28.0%) | $233.63M(+14.4%) |
| Dec 2006 | $204.19M(+35.4%) | $91.08M(+81.5%) | $204.19M(+17.3%) |
| Sep 2006 | - | $50.18M(+86.9%) | $174.08M(+10.7%) |
| Jun 2006 | - | $26.84M(-25.6%) | $157.32M(-1.9%) |
| Mar 2006 | - | $36.09M(-40.8%) | $160.31M(+6.3%) |
| Dec 2005 | $150.79M(+55.3%) | $60.97M(+82.5%) | $150.79M(+18.1%) |
| Sep 2005 | - | $33.41M(+12.0%) | $127.64M(+6.7%) |
| Jun 2005 | - | $29.83M(+12.3%) | $119.60M(+11.8%) |
| Mar 2005 | - | $26.58M(-29.7%) | $106.98M(+10.2%) |
| Dec 2004 | $97.07M(+47.0%) | $37.83M(+49.1%) | $97.07M(+21.9%) |
| Sep 2004 | - | $25.36M(+47.3%) | $79.61M(+14.9%) |
| Jun 2004 | - | $17.21M(+3.3%) | $69.27M(+1.7%) |
| Mar 2004 | - | $16.67M(-18.2%) | $68.10M(-3.4%) |
| Dec 2003 | $66.02M(-27.8%) | $20.37M(+35.6%) | $70.53M(+53.4%) |
| Sep 2003 | - | $15.03M(-6.3%) | $45.97M(-21.6%) |
| Jun 2003 | - | $16.04M(-16.0%) | $58.65M(-25.3%) |
| Mar 2003 | - | $19.09M(-556.2%) | $78.48M(-14.2%) |
| Dec 2002 | $91.44M(+11.9%) | -$4.18M(-115.1%) | $91.44M(+0.7%) |
| Sep 2002 | - | $27.70M(-22.8%) | $90.80M(-2.3%) |
| Jun 2002 | - | $35.87M(+11.9%) | $92.91M(+19.8%) |
| Mar 2002 | - | $32.05M(-764.2%) | $77.56M(+21.7%) |
| Dec 2001 | $81.70M(-23.2%) | -$4.83M(-116.2%) | $63.73M(-43.7%) |
| Sep 2001 | - | $29.82M(+45.3%) | $113.21M(+15.0%) |
| Jun 2001 | - | $20.52M(+12.6%) | $98.42M(-15.1%) |
| Mar 2001 | - | $18.22M(-59.2%) | $115.95M(+8.4%) |
| Dec 2000 | $106.35M(+96.9%) | $44.65M(+197.0%) | $106.96M(+18.6%) |
| Sep 2000 | - | $15.03M(-60.5%) | $90.21M(+8.2%) |
| Jun 2000 | - | $38.04M(+312.0%) | $83.38M(+43.6%) |
| Mar 2000 | - | $9.23M(-66.9%) | $58.06M(+7.5%) |
| Dec 1999 | $54.00M(+60.7%) | $27.90M(+240.2%) | $54.03M(+125.8%) |
| Sep 1999 | - | $8.20M(-35.6%) | $23.93M(-32.1%) |
| Jun 1999 | - | $12.73M(+144.9%) | $35.23M(+14.4%) |
| Mar 1999 | - | $5.20M(-336.4%) | $30.80M(+3.7%) |
| Dec 1998 | $33.60M(-29.1%) | -$2.20M(-111.3%) | $29.70M(-32.7%) |
| Sep 1998 | - | $19.50M(+134.9%) | $44.10M(+12.8%) |
| Jun 1998 | - | $8.30M(+102.4%) | $39.10M(-10.7%) |
| Mar 1998 | - | $4.10M(-66.4%) | $43.80M(-7.6%) |
| Dec 1997 | $47.40M(+117.4%) | $12.20M(-15.9%) | $47.40M(+3.0%) |
| Sep 1997 | - | $14.50M(+11.5%) | $46.00M(+30.7%) |
| Jun 1997 | - | $13.00M(+68.8%) | $35.20M(+34.4%) |
| Mar 1997 | - | $7.70M(-28.7%) | $26.20M(+20.2%) |
| Dec 1996 | $21.80M(-15.5%) | $10.80M(+191.9%) | $21.80M(+7.9%) |
| Sep 1996 | - | $3.70M(-7.5%) | $20.20M(+2.0%) |
| Jun 1996 | - | $4.00M(+21.2%) | $19.80M(-13.9%) |
| Mar 1996 | - | $3.30M(-64.1%) | $23.00M(-10.9%) |
| Dec 1995 | $25.80M(+11.7%) | $9.20M(+178.8%) | $25.80M(+27.1%) |
| Sep 1995 | - | $3.30M(-54.2%) | $20.30M(-16.5%) |
| Jun 1995 | - | $7.20M(+18.0%) | $24.30M(+6.6%) |
| Mar 1995 | - | $6.10M(+64.9%) | $22.80M(-1.7%) |
| Dec 1994 | $23.10M(-27.4%) | $3.70M(-49.3%) | $23.20M(-39.9%) |
| Sep 1994 | - | $7.30M(+28.1%) | $38.60M(+5.5%) |
| Jun 1994 | - | $5.70M(-12.3%) | $36.60M(+0.5%) |
| Mar 1994 | - | $6.50M(-66.0%) | $36.40M(+15.2%) |
| Dec 1993 | $31.80M(+381.8%) | $19.10M(+260.4%) | $31.60M(+122.5%) |
| Sep 1993 | - | $5.30M(-3.6%) | $14.20M(+34.0%) |
| Jun 1993 | - | $5.50M(+223.5%) | $10.60M(+158.5%) |
| Mar 1993 | - | $1.70M(0.0%) | $4.10M(+5.1%) |
| Dec 1992 | $6.60M(+32.0%) | $1.70M(0.0%) | $3.90M(+11.4%) |
| Sep 1992 | - | $1.70M(-270.0%) | $3.50M(+16.7%) |
| Jun 1992 | - | -$1.00M(-166.7%) | $3.00M(-43.4%) |
| Mar 1992 | - | $1.50M(+15.4%) | $5.30M(+39.5%) |
| Dec 1991 | $5.00M | $1.30M(+8.3%) | $3.80M(+52.0%) |
| Sep 1991 | - | $1.20M(-7.7%) | $2.50M(+92.3%) |
| Jun 1991 | - | $1.30M | $1.30M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual gross profit?
- What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual gross profit?
The current annual gross profit of VRTX is $9.49B
What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual gross profit is $9.49B
What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
Over the past year, VRTX annual gross profit has changed by +$882.60M (+10.25%)
What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
The current quarterly gross profit of VRTX is $2.49B
What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly gross profit is $2.49B
What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
Over the past year, VRTX quarterly gross profit has changed by +$338.90M (+15.76%)
What is Vertex Pharmaceuticals Incorporated TTM gross profit?
The current TTM gross profit of VRTX is $9.49B
What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM gross profit is $9.49B
What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
Over the past year, VRTX TTM gross profit has changed by +$882.60M (+10.25%)